Amélie Boichard

4PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 13, 2020
Role of ultraviolet mutational signature versus tumor mutation burden in predicting response to immunotherapy.

Timothy V Pham, Amélie Boichard, Aaron Goodman

|Oct 01, 2019
Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues.

Alex M Li, Amélie Boichard, Razelle Kurzrock

|Feb 07, 2019
APOBEC-related mutagenesis and neo-peptide hydrophobicity: implications for response to immunotherapy.

Amélie Boichard, Timothy V Pham, Huwate Yeerna

Pageof 1